Related Experiment Video
Updated: Jun 3, 2026
07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Astrocytopathy in Balo's disease
1Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. kira@neuro.med.kyushu-u.ac.jp
Multiple Sclerosis (Houndmills, Basingstoke, England)
|April 5, 2011
Summary
Baló's disease, a variant of multiple sclerosis (MS), shows characteristic concentric rings. Loss of aquaporin-4 (AQP4) in astrocytes, without antibodies, may define this condition.
Area of Science:
- Neurology
- Neuroimmunology
- Pathology
Background:
- Baló's disease presents as concentric demyelination rings, often co-occurring with multiple sclerosis (MS)-like lesions.
- Hypertrophic astrocytes and oligodendrocyte apoptosis are observed in demyelinated areas.
- The mechanism of Baló's concentric ring formation remains incompletely understood.
Purpose of the Study:
- To investigate the role of aquaporin-4 (AQP4) in Baló's disease pathology.
- To determine if AQP4 alterations are characteristic of Baló's disease, independent of anti-AQP4 antibodies.
Main Methods:
- Immunohistochemical analysis of brain tissue from Baló's disease patients.
- Assessment of AQP4 and glial fibrillary acidic protein (GFAP) expression in demyelinated and myelinated lesions.
- Serological testing for anti-AQP4 antibodies.
Main Results:
- Extensive loss of AQP4 was observed in hypertrophic astrocytes within active demyelinating lesions in Filipino Baló's patients.
- This AQP4 loss occurred in both demyelinated and myelinated areas.
- No anti-AQP4 antibodies were detected in any of the studied patients with MRI-confirmed Baló's disease.
Conclusions:
- Aquaporin-4 astrocytopathy, characterized by AQP4 loss in astrocytes without circulating antibodies, is proposed as a hallmark of Baló's disease.
- This finding suggests a novel pathogenic mechanism for Baló's disease, distinct from antibody-mediated conditions.
- Further experimental studies are warranted to validate this hypothesis.
More Related Videos
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...